Müller, R.-U., Lianne Messchendorp, A., Birn, H., Capasso, G., Cornec-Le Gall, E., Devuyst, O., Eerde, A. van, Guirchoun, P., Harris, T., Hoorn, E. J., Knoers, N. V., Korst, U., Mekahli, D., Le Meur, Y., Nijenhuis, T., Ong, A. C., Sayer, J. A., Schaefer, F., Servais, A., Tesar, V., Torra, R., & Gansevoort, S. B. W. and R. T. (2022). An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. KIDNEYS, 11(1), 37–39. https://doi.org/10.22141/2307-1257.11.1.2022.357